NCT02999022View on ClinicalTrials.gov

Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)

PHASE2RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Fractures
Interventions
DRUG

Lithium Carbonate

Intervention begins 14 days after injury for non-surgical participants and 2 weeks after surgery for participants who have surgical treatment of their fractures.

DRUG

Lactose Placebo

Intervention begins 14 days after injury for non-surgical participants and 2 weeks after surgery for participants who have surgical treatment of their fractures.

Trial Locations (5)

L4M 6M2

RECRUITING

Royal Victoria Regional Health Centre, Barrie

Unknown

RECRUITING

Hamilton Health Sciences, Hamilton

RECRUITING

Unity Health St. Michael's Hospital, Toronto

K1Y 4E9

RECRUITING

The Ottawa Hospital Civic Campus, Ottawa

M5R 3P6

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Sunnybrook Health Sciences Centre

OTHER